The safety and efficacy of the biosimilar anti-CD20 antibody, Truxima, in haematological malignancy

被引：0
|
作者：
Lo, I. [1 ]
Bansal, S. [1 ]
Arami, S. [1 ]
机构：
[1] London Northwest Healthcare NHS Trust, London, England
来源：
LEUKEMIA RESEARCH | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP-48
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] Expression and biological characterization of an anti-CD20 biosimilar candidate antibody A case study
    Dorvignit, Denise
    Palacios, Julio L.
    Merino, Maylin
    Hernandez, Tays
    Sosa, Katya
    Casaco, Angel
    Lopez-Requena, Alejandro
    Mateo de Acosta, Cristina
    MABS, 2012, 4 (04) : 488 - 496
  • [2] Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus
    Iwata, S.
    Saito, K.
    Hirata, S.
    Ohkubo, N.
    Nakayamada, S.
    Nakano, K.
    Hanami, K.
    Kubo, S.
    Miyagawa, I.
    Yoshikawa, M.
    Miyazaki, Y.
    Yoshinari, H.
    Tanaka, Y.
    LUPUS, 2018, 27 (05) : 802 - 811
  • [3] Efficacy and safety of an anti-CD20 monoclonal antibody, rituximab, for lupus nephritis: A meta-analysis
    Teng, Siyuan
    Tian, Yu
    Luo, Nan
    Zheng, Qiang
    Shao, Mingfang
    Li, Lei
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (02) : 101 - 109
  • [4] Safety and Efficacy of an Anti-CD20 Monoclonal Antibody (Reditux (TM)) In Indian Patients with Seropositive Rheumatoid Arthritis
    Hegde, Arun
    Vasdev, Vivek
    Shanmuganandan, Krishnan
    Singh, Kavita
    Kartik, Sivasami
    Kumar, Abhishek
    INDIAN JOURNAL OF RHEUMATOLOGY, 2018, 13 (01) : 20 - 25
  • [5] Anti-CD20 monoclonal antibody in autoimmune diseases
    Pogliani, EM
    Larocca, A
    BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (07) : 350 - 351
  • [6] Ofatumumab, a human anti-CD20 monoclonal antibody
    Osterborg, Anders
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 439 - 449
  • [7] Anti-CD20 antibody wows in multiple sclerosis
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2015, 33 (12) : 1215 - 1216
  • [8] Measuring CD20 binding for humanization of anti-CD20 antibody
    Meng, YJG
    Hong, K
    Presta, L
    Penn, A
    Adams, C
    Chuntharapai, A
    Yang, JH
    Lu, YM
    Wong, WL
    FASEB JOURNAL, 2004, 18 (04): : A59 - A59
  • [9] Ofatumumab: a novel monoclonal anti-CD20 antibody
    Lin, Thomas S.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 51 - 59
  • [10] Anti-CD20 antibody wows in multiple sclerosis
    Cormac Sheridan
    Nature Biotechnology, 2015, 33 : 1215 - 1216
12345